Neo-Ceftazidime Pediatric 250mg Vial from Canada
Pediatric-strength 250mg ceftazidime vial for neonatal sepsis treatment. HTS 3004.20.00.72 as measured dose containing ceftazidime salts for prophylactic/therapeutic use in retail packs. Lower dose for weight-based dosing.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include age-appropriate dosing info and contraindication labels
• Source from GMP-certified facilities with pediatric exclusivity data
• Avoid adult strength mislabeling for correct pediatric classification